The results showed a statistically significant decrease in the expression of THTR-1 and THTR-2 mRNAs (P < 0.01 for both) in these two brain regions of AD patients compared to control subjects (Figs. 1B and 2B). This evidence concerns the gene SLC19A3 and Alzheimer disease.